Skip to main content

FIND Joins CARB-X to Support Development of Diagnostics to Combat Antimicrobial Resistance

NEW YORK (360Dx) – The Foundation for Innovative New Diagnostics (FIND) is joining the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) Global Accelerator Network, the organizations announced today.

The CARB-X Global Accelerator Network now includes 10 organizations that provide business, scientific, and technical expertise and services to CARB-X-funded companies to support their antibacterial research projects.

FIND, a global non-profit organization that supports development of diagnostics to combat major diseases affecting poor populations, will play a leading role in supporting CARB-X diagnostic investments. FIND will support new applicants for CARB-X funding for the development of diagnostics and help companies assess how diagnostic solutions could be used in resource-poor settings.

FIND CEO Catharina Boehme said in a statement that accurate, accessible diagnostics for AMR are urgently needed alongside new antibiotics and vaccines.